Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name listmopidamol

mopidamol

  • CAS NO.:13665-88-8
  • Empirical Formula: C19H31N7O4
  • Molecular Weight: 421.499
  • MDL number: MFCD00867237
  • EINECS: 2371456
  • SAFETY DATA SHEET (SDS)
  • Update Date: 2026-01-20 14:53:06
mopidamol  Structural

What is mopidamol ?

Originator

Rapenton,Thomae,W. Germany,1980

Definition

ChEBI: Mopidamol is a tertiary amino compound and a dialkylarylamine.

Manufacturing Process

3.9 g (0.06 mol) of zinc powder were introduced into a solution of 5.0 g (0.01 mol) of 2,6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-[5,4-d]-pyrimidine (dipyridamole; see entry under that name for its synthesis) in 120 cc of aqueous 10% formic acid. The resulting mixture was heated on a water bath, while occasionally stirring, until the intense yellow color of the starting compound disappeared, which occurred after about 30 to 40 minutes. Thereafter, the unconsumed zinc powder was separated by vacuum filtration, the virtually colorless filtrate was essentially an aqueous solution of 2,6-bis- (diethanolamino)-8-piperidino-1,2,3,4-tetrahydropyrimido-[5,4-d]pyrimidine.
The filtrate was adjusted to a pH of 9 by adding concentrated ammonia, and then a 1 N aqueous iodine-potassium iodide solution was added dropwise, whereby the tetrahydropyrimido[5,4-d]pyrimidine obtained by hydrogenation with zinc in formic acid was converted by oxidation into 2,6-bis- (diethanolamino)-8-piperidino-pyrimido-[5,4-d]-pyrimidine. The completion of the oxidation was checked by means of a starch solution. The major amount of the oxidation product already separated out as a deep yellow crystalline precipitate during the addition of the iodine solution. After the oxidation reaction was complete, the reaction mixture was allowed to stand for a short period of time, and then the precipitate was separated by vacuum filtration,washed with water and dried. It had a melting point of 157°C to 158°C. The yield was 8.0 g, which corresponds to 95% theory.

Therapeutic Function

Platelet aggregation inhibitor

Properties of mopidamol

Melting point: 157-158°
Boiling point: 738.6±70.0 °C(Predicted)
Density  1.401±0.06 g/cm3(Predicted)
pka 13.85±0.10(Predicted)

Safety information for mopidamol

Computed Descriptors for mopidamol

Related products of tetrahydrofuran

You may like

  • 2847776-12-7 Sumatriptan Succinate USP Related Compound C NLT 95%
    2847776-12-7 Sumatriptan Succinate USP Related Compound C NLT 95%
    2847776-12-7
    View Details
  • 1012886-75-7(HCl Salt)/69675-10-1(Freebase) Paroxetine  Impurity G/Paroxetine Related Compound E NLT 95%
    1012886-75-7(HCl Salt)/69675-10-1(Freebase) Paroxetine Impurity G/Paroxetine Related Compound E NLT 95%
    1012886-75-7(HCl Salt)/69675-10-1(Freebase)
    View Details
  • 2856-63-5 99%
    2856-63-5 99%
    2856-63-5
    View Details
  • 3,4 Diethoxy Benzylcyanide 99%
    3,4 Diethoxy Benzylcyanide 99%
    27472-21-5
    View Details
  • Bromoacetaldehyde Dimethyl Acetal (stabilized with K2CO3)
    Bromoacetaldehyde Dimethyl Acetal (stabilized with K2CO3)
    7252-83-7
    View Details
  • 157528-56-8 (R)-1-Benzyl-3-pyrrolidinecarbonitrile 98+
    157528-56-8 (R)-1-Benzyl-3-pyrrolidinecarbonitrile 98+
    157528-56-8
    View Details
  • 157528-56-8 (R)-1-Benzyl-3-pyrrolidinecarbonitrile 98+
    157528-56-8 (R)-1-Benzyl-3-pyrrolidinecarbonitrile 98+
    157528-56-8
    View Details
  • 5-azidovalericacid
    5-azidovalericacid
    79583-98-5
    View Details
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.